Pancreatic Cancer Research

ResearcherMoffitt Cancer CenterActive in the last 2 years

Brian G. Czito

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5074-767X; OpenAlex author ID A5059865374, A5158584168. Sources: ClinicalTrials.gov.

Their work

Papers
13 (first author 2, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
89
Papers, trials and grants by year

2011: 1 paper, 1 trial · 2012: 2 papers · 2013: none · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 13

  1. Pancreatic Adenocarcinoma, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology. Co-author DOI 10.6004/jnccn.2026.0046↗
  2. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-control… Co-author DOI 10.1016/s1470-2045(23)00478-3↗
  3. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2021.0017↗
  4. Randomized, Double-Blinded, Placebo-controlled Multicenter Adaptive Phase 1-2 Trial of GC 4419, a Dismutase Mimetic, in Combination with High Dose Stereotactic… Co-author DOI 10.1016/j.ijrobp.2020.09.022↗
  5. Pancreatic Adenocarcinoma, Version 1.2019. Co-author DOI 10.6004/jnccn.2019.0014↗
  6. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology. Co-author DOI 10.6004/jnccn.2017.0131↗
  7. A current perspective on stereotactic body radiation therapy for pancreatic cancer. First author DOI 10.2147/ott.s99826↗
  8. Adjuvant radiation therapy for pancreatic cancer: a review of the old and the new. First author DOI 10.3978/j.issn.2078-6891.2015.014↗
  9. The role of intraoperative radiation therapy in patients with pancreatic cancer. Last author DOI 10.1016/j.semradonc.2013.11.004↗
  10. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. Co-author DOI 10.6004/jnccn.2014.0106↗
  11. Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer? Co-author DOI 10.1002/jso.23044↗
  12. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. Co-author DOI 10.6004/jnccn.2012.0073↗
  13. Role of radiation therapy in patients with resectable pancreatic cancer. Last author PMID 21874833↗

Trials 1

  1. Magnetic Resonance Imaging (MRI) in Motion Principal investigator NCT02019199↗

Closest collaborators

The 25 strongest of 89 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Robert A. Wolff · 7 shared papers, 2012–2026 · strength 0.55
  2. Mokenge Peter Malafa · 7 shared papers, 2012–2026 · strength 0.55
  3. Manisha Palta · 6 shared papers, 2011–2023 · strength 0.48
  4. Andrew H. Ko · 6 shared papers, 2012–2026 · strength 0.43
  5. Eric K. Nakakura · 6 shared papers, 2012–2026 · strength 0.43
  6. Brian Matthew Wolpin · 6 shared papers, 2012–2026 · strength 0.43
  7. Al B. Benson · 6 shared papers, 2012–2026 · strength 0.43
  8. Andrew M. Lowy · 5 shared papers, 2014–2026 · strength 0.41
  9. Vincent M. Chung · 5 shared papers, 2014–2026 · strength 0.41
  10. Elena Gabriela Chiorean · 5 shared papers, 2014–2026 · strength 0.41
  11. Todd Anthony Aguilera · 3 shared papers, 2020–2026 · strength 0.40
  12. Noelle K. LoConte · 4 shared papers, 2017–2026 · strength 0.38
  13. Courtney L. Scaife · 4 shared papers, 2017–2026 · strength 0.38
  14. Jeffrey M. Hardacre · 4 shared papers, 2017–2026 · strength 0.38
  15. Dana Backlund Cardin · 4 shared papers, 2017–2026 · strength 0.38
  16. Mary E. Dillhoff · 4 shared papers, 2017–2026 · strength 0.38
  17. Christos K Fountzilas · 3 shared papers, 2019–2026 · strength 0.33
  18. Amol Kumar Narang · 3 shared papers, 2019–2026 · strength 0.33
  19. Joseph M. Herman · 5 shared papers, 2012–2023 · strength 0.30
  20. Christopher G. Willett · 5 shared papers, 2011–2016 · strength 0.30
  21. Timothy R. Donahue · 2 shared papers, 2021–2026 · strength 0.27
  22. Charles M. Vollmer · 2 shared papers, 2021–2026 · strength 0.27
  23. Marsha Reyngold · 2 shared papers, 2021–2026 · strength 0.27
  24. Patricio Marcelo Polanco · 2 shared papers, 2021–2026 · strength 0.27
  25. John W. Kunstman · 2 shared papers, 2021–2026 · strength 0.27

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.